Just as GLP-1 medications purportedly address a variety of wellness issues, from weight loss to blood sugar control and metabolic health, the influence of these medications can be seen across a range of CPG categories. Circana’s latest insights confirm that the much-buzzed-about ripple effect is real, with waves expanding beyond food and beverage into a host of non-food and general merchandise segments.